Quantitation of the Calcium and Membrane Binding Properties of the C2 Domains of Dysferlin  by Abdullah, Nazish et al.
382 Biophysical Journal Volume 106 January 2014 382–389Quantitation of the Calcium and Membrane Binding Properties of the C2
Domains of DysferlinNazish Abdullah, Murugesh Padmanarayana, Naomi J. Marty, and Colin P. Johnson*
Department of Biochemistry and Biophysics, Oregon State University, Corvallis, OregonABSTRACT Dysferlin is a large membrane protein involved in calcium-triggered resealing of the sarcolemma after injury.
Although it is generally accepted that dysferlin is Ca2þ sensitive, the Ca2þ binding properties of dysferlin have not been char-
acterized. In this study, we report an analysis of the Ca2þ and membrane binding properties of all seven C2 domains of dysferlin
as well as a multi-C2 domain construct. Isothermal titration calorimetry measurements indicate that all seven dysferlin C2
domains interact with Ca2þ with a wide range of binding affinities. The C2A and C2C domains were determined to be the
most sensitive, with Kd values in the tens of micromolar, whereas the C2D domain was least sensitive, with a near millimolar
Kd value. Mutagenesis of C2A demonstrates the requirement for negatively charged residues in the loop regions for divalent
ion binding. Furthermore, dysferlin displayed significantly lower binding affinity for the divalent cations magnesium and stron-
tium. Measurement of a multidomain construct indicates that the solution binding affinity does not change when C2 domains
are linked. Finally, sedimentation assays suggest all seven C2 domains bind lipid membranes, and that Ca2þ enhances but
is not required for interaction. This report reveals for the first time, to our knowledge, that all dysferlin domains bind Ca2þ albeit
with varying affinity and stoichiometry.INTRODUCTIONDamage to the plasma membrane of mammalian cells
occurs routinely, and is frequently an outcome of their
physiological function. For example, the mechanical activ-
ity of cardiac and skeletal muscle often leads to tears and
disruptions of the plasma membrane (1–4). In response to
membrane disruption, an elaborate membrane repair system
is found in many types of cells that reseals the membrane
and prevents cell death. This repair mechanism is dependent
on the flow of extracellular Ca2þ into the wounded cell,
which is thought to trigger membrane repair proteins
(3,5). Dysferlin is believed to play a central role as a Ca2þ
sensor and as a direct effector in this process. In support
of this, dysferlin-null mice are unable to exclude fluorescent
dyes from entering muscle tissue after wounding, and
dysferlin knockdown zebrafish are deficient in their ability
to repair sarcolemma lesions (6–10). In humans, mutations
in dysferlin have been linked to a group of muscular
dystrophies known as dysferlinopathies that are character-
ized by muscle atrophy and increased amounts of adipose
tissue (11–18). Beyond muscle, dysferlin is expressed at
lower levels in several other cell types, including mono-
cytes, where it may regulate cell adhesion and chemotaxis
(19–21).
Dysferlin is one member of the ferlin family of proteins.
First characterized in Caenorhabditis elegans, ferlin pro-
teins are composed of multiple N-terminal C2 domains
followed by a C-terminal single-pass transmembrane re-
gion (Fig. 1) (22,23). Dysferlin possesses seven C2
domains and typically resides on the sarcolemma mem-Submitted June 10, 2013, and accepted for publication November 27, 2013.
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0006-3495/14/01/0382/8 $2.00brane, although it has also been detected on intracellular
vesicles (23,24). Canonically, the C2 domain is a Ca2þ
and phospholipid binding motif found in many mem-
brane-binding proteins, and Ca2þ binding often facilitates
domain interaction with membranes (25–28). C2 domains
consist of a beta-sandwich fold, and the coordination of 2
or 3 Ca2þ ions is typically mediated by 4–5 conserved
aspartate residues found on the loops at one end of the
domain. However, not all C2 domains bind Ca2þ, and
some C2 domains are believed rather to act as spacers
or contribute structurally to the protein. Analysis of the
dysferlin sequence indicates that although C2 domains at
the C-terminus share the conserved five conserved aspar-
tates, C2 domains at the N-terminus show fewer conserved
aspartates, with only three aspartates in the loops of the
C2A domain (29). On this basis, it might be predicted
that the N-terminal domains (C2A, C2B, and C2C) do
not bind Ca2þ. Indeed, the C2A domain of the mammalian
dysferlin homolog otoferlin does not bind Ca2þ (30,31).
Surprisingly however, recent reports concluded that
binding of the dysferlin C2A domain to lipids was
enhanced in the presence of Ca2þ, providing indirect
evidence of Ca2þ binding activity for this domain
(29,32). As yet, no study has directly measured the Ca2þ
binding activity of each C2 domain. In this study, we
address this shortcoming by measuring the Ca2þ binding
properties of all seven C2 domains of dysferlin in solution
and measure how Ca2þ modulates the membrane binding
activity of the domains. In addition, mutagenesis studies
were also conducted to identify residues responsible for
Ca2þ binding.http://dx.doi.org/10.1016/j.bpj.2013.11.4492
FIGURE 1 Schematic diagram of full-length human dysferlin. Dysferlin
is composed of seven tandem C2 domains (ovals labeled A through G) and a
single-pass transmembrane domain (labeled TMD). Non-C2 domain folds
including Fer domains (small black rectangles) and the DYSF domain
(large black rectangle) are also indicated. Recombinant proteins composed
of isolated C2 domains were generated according to the amino acid desig-
nations listed.
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Materials
Lipids were purchased from Avanti Polar Lipids (Alabaster, AL). Ni2þ-
Sepharose beads were purchased from GE-Amersham Biosciences (Pitts-
burgh, PA). Reagents were obtained from Sigma (St. Louis, MO).Protein expression and purification
All primers were purchased from Sigma Aldrich. Constructs were verified
by sequencing by the Center for Genome Research and Biocomputing core
facility at Oregon State University. pcDNA4/TO/mGFP-dysferlin-myc-his
(gift from K. Bushby, Newcastle, UK) was used as a template for amplifi-
cation of human dysferlin (GenBank: AF075575.1). Primers were designed
for the coding sequences with 50 and 30 sites for ligase independent cloning
insertion into SspI/T4-treated pMCSG9 vector (33). Primers for the C2
domains were based upon the predicted boundaries as reported previously
(29,34) (see Fig. 1). Dysferlin C2A mutations were constructed using the
Stratagene Quickchange site-directed mutagenesis kit with the pMCSG9/
6His-MBP-dysferlin C2A plasmid as a template. The constructs were trans-
formed into BL21 cells and expressed as a fusion with 6XHis-MBP
(maltose-binding protein). Expressed constructs were affinity purified using
Ni2þ-NTA resin. ATEV protease site allowed for cleavage of the purifica-
tion tag when desired. Purified proteins were washed with 1 mM EDTA to
remove any prebound cations followed by extensive dialysis to eliminate
the EDTA. The protein concentrations were measured using calculated
extinction coefficient based on protein sequence. To ensure that the proteins
were properly folded, circular dichroism (CD) spectra of the C2 domains
were collected after removal of the MBP via restriction digestion with TEV.Isothermal titration calorimetry (ITC)
ITC studies were conducted on both VP-ITC (GE Healthcare, Pittsburgh,
PA) and Nano ITC instruments (TA Instruments, New Castle, DE). The pro-
teins were dialyzed extensively in buffer containing 50 mM Tris-HCl
pH 7.5 and 100 mM NaCl. The titrant was prepared in the dialysate.
Proteins were placed in the cell while CaCl2 was used as the titrant in the
syringe. All experiments were conducted at 37C with a stirring speed of
250 rpm. The titration temperature of 37C was chosen for its physiological
relevance. However, to ensure that the results are temperature independent
we carried out C2A Ca2þ binding at 25C and found the data to be similar.
A typical titration involved 20 or more injections. Protein concentrationsused were 330 mM C2A, 408 mM C2B, 754 mM C2C, 363 mM C2D,
471 mM C2E, 393 mM C2F, 322 mM C2G, 742 mM C2BC, 750 mM
C2A-R79D, and 950 mM C2A-F80A. Each experiment was accompanied
by a buffer titration in which the Ca2þ at the experimental concentration
was titrated against the buffer. The buffer data were subtracted from the
corresponding experiment before data fitting. All experiments were
repeated a minimum of three times.Data fitting for ITC
The data were fitted using the Nano ITC or Origin analysis software. Data
were fitted using single-, two-, or three-site models (three or five for C2BC)
and the best fit was used to deduce the thermodynamic parameters. All the
experiments were conducted in triplicate; the three sets of data were used to
calculate mean and standard error values. Stoichiometry was calculated
based on the midpoint of titration on the x axis and further corroborated
with the sum of the calculated n values in the fit.Homology modeling
To determine the aspartate residues most likely to contribute to Ca2þ
binding by the C2A domain, Swiss model (http://swissmodel.expasy.org/)
was used to create a homology model of dysferlin C2A. The known
NMR structure for the human myoferlin C2A (PDB id-2DMH) was used
as the template.Lipid binding studies
Liposomes composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine
(POPS) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
were made via extrusion with 50 nm cutoff membrane, as described previ-
ously (29,35). Lipid binding was studied by sedimentation of the C2
domain with liposomes of desired composition in EDTA or divalent cations
(calcium, magnesium, or strontium) (29). Briefly, the liposomes and
proteins were incubated in the presence or absence of divalent cations,
followed by centrifugation at 85,000 rpm in Beckman TL-100 ultracentri-
fuge. 1 mM of lipids and 5 mM of proteins were used. The protein was
also centrifuged in the absence of liposomes to validate C2 domain solubi-
lity. The supernatant and pellet were analyzed by SDS-PAGE.RESULTS
All seven C2 domains of dysferlin harbor Ca2D
binding activity
No previous study has directly measured the Ca2þ binding
affinity or stoichiometry for any of the C2 domains of
dysferlin. To obtain these values, we measured the binding
between Ca2þ and isolated C2 domains of dysferlin using
ITC. When tested, all seven C2 domains of dysferlin bound
Ca2þ (Fig. 2). The dysferlin C2B, C2D, C2G domains were
best fit with a one-site equation. whereas C2A, C2C, C2E,
and C2F domains fit best with a two-site equation. The fitted
values are reported in Table 1, and exhibited a wide range of
Kd values, from micromolar for C2A to near millimolar for
C2D and C2E. Inspection of the binding stoichiometries
indicate that the domains bound either two or three Ca2þ
ions, consistent with stoichiometries reported for other C2
domains (25,36–38). The data also showed that Ca2þ bind-
ing for C2C, C2D, and C2E were endothermic, whereasBiophysical Journal 106(2) 382–389
FIGURE 2 Ca2þ binding by different C2 domains of dysferlin. The different domains are labeled, respectively. Controls include the MBP and otoferlin
C2A. For each domain the top panel shows the raw heat rate and the lower panel shows the integrated heats and fit. The concentrations of proteins and Ca2þ
have been indicated in the Materials and Methods. All titrations were carried out at 37C. The models used for fitting the data are mentioned in Table 1.
384 Abdullah et al.those of C2B and C2G were exothermic. Titrations for C2A
and C2F were composed of both exothermic and endo-
thermic components (Table 1).The linker between C2 domains has no significant
effect on binding stoichiometry or affinity
The C2 domains of dysferlin are coupled via long linker
regions that are believed to be predominantly unstructured
based on secondary structure predictions. Whether these
linkers alter the properties of the C2 domains has not been
determined. To ascertain whether coupling via linkers
affects the Ca2þ binding properties of the C2 domains, we
conducted ITC on a dysferlin construct composed of the
C2B and C2C domains joined by their endogenous linker
(amino acids 219–528). This segment of dysferlin was
chosen due to the contrasting exothermic and endothermicTABLE 1 Thermodynamic parameters for Ca2D binding by the C2
Domain Model used Stoichiometry (n) DH1 (kCal/mol) DH2 (kCal/m
A 2-site 2(1.8) 0.165 0.13 1.85 0.0
B 1-site 2(1.7) 0.375 0.03 –
C 2-site 3(3.3) 0.25 0.03 0.75 1.1
D 1-site 2(2.5) 0.365 0.01 –
E 2-site 3(2.8) 0.255 0.06 0.225 0.0
F 2-site 3(3.1) 7.85 0.5 8.250.6
G 1-site 2(1.7) 1.85 0.2 –
BC 3-site 5 4.95 1.1, 30.45 5.6 41.45 9.1
Each titration was repeated at least three times. Stoichiometry was calculated
parentheses) from the fit.
Biophysical Journal 106(2) 382–389properties of the domains (Table 1). The resultant ITC titra-
tion appeared to be the superposition of C2B and C2C, and
was best fit with a three-site model that yielded Kd values
approximately equivalent to the Kd values for the individual
C2B and C2C domains (Fig. 3, Table 1). In addition, a plot
of molar ratio versus kcal/mole suggested an approximate
stoichiometry of five Ca2þ per protein, which was in good
agreement with the sum of the individual C2 domains
composing this construct. Thus, we conclude that the linker
does not alter the Ca2þ binding properties of the domains.The dysferlin C2A domain binds Mg2Dand Sr2D
with low affinity
Free Ca2þ is tightly regulated by the cell, and the concentra-
tion of Mg2þ often exceeds Ca2þ by more than an order
of magnitude. Many C2 domains, including those ofdomains of dysferlin as determined by ITC
ol) kd1 mM kd2 mM DS(cal/mol.K)
5 3.75 0.7 80 5 2 24.95 7.5,12.65 2.1
1795 12.1 – 46.95 9.1
1.55 0.1 178.25 12.2 27.45 0.2,19.45 2.5
8275 100 – 15.35 4.4
7 3015 24 9865 37 16.95 2.1;14.55 0.8
1865 5.2 2505 12.1 -8.15 0.4;43.4 5 4.2
124.25 1.3 – 82.255 4.4
5.35 1.4; 2305 7.5 1585 8.1 225 4.1,215 3.3, 14.75 0.1
from the midpoint of the titration curve and from the sum of n values (in
FIGURE 3 The endogenous linker region between C2B and C2C does
not affect Ca2þ binding. A construct containing the C2B and C2C domains
of dysferlin was titrated with Ca2þ. Analysis of the thermogram indicates
that the affinities of the C2 domains are unaltered by the linker (Table 1).
FIGURE 4 The C2A domain of dysferlin binds weakly to Mg2þ and
Sr2þ. (A) Representative thermogram of C2A titrated with Mg2þ.
640 mM dysferlin C2Awas titrated with 10 mM MgCl2. (B) Representative
thermogram of C2A titrated with Sr2þ. 330 mM C2A was titrated with
5 mM SrCl2. (C) Representative thermogram showing that Ca
2þ can
compete with Mg2þ for binding to C2A. Protein was prebound to
750 mMMg2þ and then titrated with 5 mMCaCl2. (D). Representative ther-
mogram of C2A prebound with 750 mM Ca2þ titrated with 5 mM MgCl2.
No binding was observed.
Ca2þ Binding by Dysferlin. 385synaptotagmin I bind Ca2þ with high specificity, and do not
interact with Mg2þ at normal cellular concentrations. To test
the specificity of Ca2þ binding, we measured the Mg2þ and
Sr2þ binding affinities for the C2A domain using ITC. The
data revealed lower binding affinities as compared to Ca2þ
(Fig. 4, A and B, Table 2). Both sets of data were fit to a
two-site model. Binding to Mg2þ was endothermic, whereas
binding to Sr2þ was exothermic. We next asked whether the
presence of Mg2þ can hamper Ca2þ binding by carrying out
Ca2þ titrations on C2A protein prebound to 750 mM Mg2þ,
the approximate concentration of free Mg2þ in cell
cytoplasm (39). The results indicate that Ca2þ can success-
fully displace Mg2þ and bind to the C2A domain (Fig. 4 C).
The reverse experiment, where the protein was prebound to
750 mM Ca2þ and then challenged with Mg2þ showed no
binding (Fig. 4 D). Thus, the C2A domain of dysferlin binds
preferentially to Ca2þ.Mutational analysis of dysferlin C2A
The results of our ITC measurements indicate that the C2A
domain harbors appreciable binding affinity for Ca2þ
despite possessing only three of the five canonical aspartate
residues that traditionally mediate divalent ion coordination
(Fig. 5 A). To identify whether the remaining aspartates
contribute to Ca2þ binding, a homology model of C2A
was generated using the NMR structure of myoferlin C2A
(PDB id-2DMH), which has a 40% identity with dysferlinC2A (Fig. 5 B). This model places the three aspartates
(D16, D21, and D71) in the loop regions of the domain in
close proximity, suggesting that they could participate in
binding (Fig. 5 B). In an attempt to ascertain whether
D16, D21, and D71 are required for metal ion coordination,
we mutated each residue individually and tested the Ca2þ
binding properties using ITC. To ensure that the mutants
are properly folded and possess a structure similar to the
wild-type, CD measurements were carried out. The CD
spectra of the three mutants show that the proteins are folded
and have a structure similar to the wild-type. When tested,
all three mutants failed to bind Ca2þ (Fig. 5 D). A second
model of the putative Ca2þ binding loops based upon synap-
totagmin I C2A is shown in Fig. 4 C, and provides a possible
structural basis for Ca2þ coordination. According to the
model in Fig. 4 C, R79 resides in place of a conservedBiophysical Journal 106(2) 382–389
TABLE 2 Thermodynamic parameters for binding of divalent
cations to dysferlin C2A
Ion
Kd DH DS
mM kcal/mol cal/mol.deg
Ca2þ 3.75 0.7 0.165 0.13 24.95 2.5
805 2 1.85 0.05 12.65 1.2
Mg2þ 64.95 45.7 0.45 0.2 20.45 5.5
1.4x10350.6  103 0.65 0.1 15.05 3.1
Sr2þ 91.75 0.5 0.45 0.03 17.15 3.2
7x10354  103 0.35 0.06 10.15 1.4
Mg2þ/Ca2þ
competition
785 52 0.045 2  103 18.95 2.1
2.95 1.7 0.85 0.01 22.75 1.1
R79D 1.85 0.7 2.35 0.9 28.45 3.7
6.45 3.7 0.85 0.2 16.15 1.3
F80A 464.65 10.7 0.65 0.1 13.35 1.7
224.35 5.7 0.95 0.06 19.75 1.4
386 Abdullah et al.aspartate residue found in synaptotagmin I C2A that con-
tributes to Ca2þ binding. We next asked if a R79D mutant
would alter the binding affinity of dysferlin C2A. In addi-
tion, we also mutated the proximal F80 to ascertain the
effect of noncharged loop residues on Ca2þ binding proper-
ties of C2A. As shown in Fig. 5 E and Table 2, neither
mutation resulted in alteration of the stoichiometry. How-
ever, the fitted Kd values for the R79D mutant suggested a
moderate increase in affinity, whereas the best fit to the
F80A data suggested reduced binding affinity.FIGURE 5 Conserved aspartates in C2A mediate Ca2þ binding (A)
Sequence and (B) Homology model of the dysferlin C2A showing the loca-
tion of the three aspartate residues chosen for mutation. (C) Model of loops
1 and 3 of dysferlin C2A indicating aspartate residues implicated in Ca2þ
binding. Residues in gray represent homologous residues in synaptotagmin
I C2A. (D) ITC data for D16A, D21A, and D71A. (E) ITC data for R79D
and F80A mutants.
Biophysical Journal 106(2) 382–389The C2 domains of dysferlin bind lipid
membranes
The Ca2þ and membrane binding activity of many C2
domains are often coupled, with the headgroups of lipids
often contributing to the coordination of the divalent ion
(28,38,40). We therefore sought to determine the effects of
Ca2þ on the lipid binding properties of dysferlin C2
domains by performing sedimentation assays on POPC/
POPS liposomes mixed with the C2 domains of dysferlin
in the presence of Ca2þ or EDTA. When tested, all seven
domains bound liposomes in the presence of EDTA, and
binding was enhanced in the presence of Ca2þ (Fig. 6 A,
top). No significant C2 domain binding was observed
when assays were conducted with 100% POPC liposomes,
demonstrating the requirement for anionic lipids (Fig. 6 A,
bottom). Analysis of Ca2þ titrations from 0 to 1 mM
revealed enhanced binding at low (~1–10 mM) Ca2þ con-
centrations for C2A and the C-terminal domains C2E,
C2F, and C2G (Fig. 6 B). Higher Ca2þconcentrations were
required for significant increases in liposome binding for
C2B, C2C, and C2D (Fig. 6 B). Aspartate mutations that
abrogate Ca2þ binding for C2A also eliminated the Ca2þ
sensitivity of C2A-liposome binding (Fig. 6 C).
The results presented in Fig. 6 A show the requirement
for negatively charged lipids like phosphatidylserine for
dysferlin-membrane binding. To determine whether electro-
static interactions contribute to the binding activity, we con-
ducted sedimentation assays in the presence of 100 or
200 mM NaCl. For six of the seven C2 domains, increased
salt lead to a reduction of binding, with C2A the most
sensitive (Fig. 6 D). Reduction in the POPS mol fraction
also resulted in attenuated binding for the domains, further
supporting a role for electrostatics in dysferlin-membrane
interactions (Fig. 6 D). Finally, we tested for the effects of
Mg2þ and Sr2þ on C2-membrane interaction. Binding in
the presence of 1 mMMg2þ or 1 mM Sr2þ was less efficient
than 1 mM Ca2þ for all domains, suggesting that the effects
of Ca2þ on membrane binding are divalent ion specific
(Fig. 6 D).DISCUSSION
In this study, we have determined that all seven domains of
dysferlin bind Ca2þ, with a broad range of Kd values. Our
findings represent the first, to our knowledge, quantitative
examination of the intrinsic Ca2þ binding properties of the
protein and demonstrate that domains in addition to C2A
could act as Ca2þ sensors for membrane trafficking events.
For comparison, the C2B domain of the synchronous cal-
cium sensor synaptotagmin I binds Ca2þ with Kd values
of 0.3–0.6 mM in solution (38), whereas the C2B domain
of the asynchronous calcium sensor DOC2B binds Ca2þ
ions with an apparent Kd value of ~10 mM in the absence
of membranes (41). The differences in binding affinities
FIGURE 6 Association of dysferlin C2 domains with liposomes. (A) Interaction of C2 domains with liposomes composed of 65% POPS and 35% POPC
under increasing Ca2þ concentrations. Sedimentation assays with 100% POPC liposomes indicate that the domains do not associate with neutral lipids. (B)
Quantitation of the results of liposome assay from panel A. (C) Sedimentation assays conducted with mutant forms of C2A. (D) C2 domain-lipid interaction
with different salt, lipid composition, and divalent cations. C2 domains have been labeled as A through G. Error bars represent standard deviation.
Ca2þ Binding by Dysferlin. 387between synaptotagmin I and DOC2B directly relate to their
abilities to affect distinct physiological functions. It may be
that the different binding affinities of the C2 domains of
dysferlin allow the protein to mediate different Ca2þ-regu-
lated events. We note that in vitro wounding studies required
a minimum of 300 mM Ca2þ in the extracellular media for
membrane resealing, consistent with the involvement of a
low affinity Ca2þ sensor (5).
Previous studies have established that many C2 domain
proteins, including synaptotagmin I, employ an electrostatic
switch mechanism whereby the Ca2þ binding affinity of the
domain increases in the presence of anionic lipids (25,38).
Our results indicate that Ca2þ enhances membrane binding
for C2A, C2E, C2F, and C2G to a greater extent than C2B
and C2D, and that all seven domains possess some Ca2þ
independent membrane binding activity. Thus, some do-
mains within dysferlin may not be as dependent on electro-
statics as those of synaptotagmin, with hydrophobic
interactions possibly playing a larger role. The interaction
between the dysferlin C2 domains and membranes does
appear to have some electrostatic components however, ashigher salt or lower phosphatidylserine reduced binding.
We speculate that electrostatic interactions are responsible
for proper membrane targeting, whereas hydrophobic
effects contribute to binding affinity.
Previous investigations on other C2 domain-containing
proteins have established the necessity of a set of highly
conserved aspartate residues in the loops of the domain
for binding Ca2þ (25,27,28,40–44). In the case of dysferlin,
the conservation of these aspartates varies by the domain,
and this difference may account for the range of binding
affinities observed in our study. Our mutagenesis studies
on the C2A domain suggest that those aspartate residues
predicted to be present in the loops of the domains by
both sequence alignment and homology modeling play a
functional role in binding Ca2þ and membranes. Other non-
aspartate loop residues also appear to contribute, including
F80. However, it remains unclear as to how noncanonical
aspartates contribute to the measured binding affinities in
dysferlin. Future studies should focus on the generation of
chimeric C2 domains with loops of alternate composition
to address this issue.Biophysical Journal 106(2) 382–389
388 Abdullah et al.Given that multiple dysferlin C2 domains interact with
Ca2þ, it would be interesting to determine the effects of
loss of Ca2þ binding for individual domains on resealing
and other dysferlin-mediated trafficking events. For
example, the aspartate to alanine mutations tested in this
study may affect certain membrane trafficking events
without perturbing others. These loop mutations may be
more informative than domain deletions, which are more
prone to mislocalization. Future work should also focus on
determining whether the Ca2þ binding properties of other
ferlins are similar or are divergent from dysferlin.CONCLUSION
Using ITC to measure Ca2þ binding we have demonstrated
that all seven C2 domains of dysferlin bind Ca2þ. The affin-
ity for each domain varies considerably, with C2A and C2C
possessing the highest affinity and the other domains
possessing affinities 20- to 100-fold lower. The wide range
of Ca2þ binding affinities observed for the C2 domains
might have significant implications for the protein, as each
domain might be tuned for activation at a particular Ca2þ
concentration.
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